Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > someone is loading up
View:
Post by peter75 on Sep 13, 2016 10:15am

someone is loading up

194 k shares traded in the first 45 minutes, equals 45 percent of the daily volume
Comment by lscfa on Sep 13, 2016 10:37am
.......CXR refugees?
Comment by Frostyfresh on Sep 13, 2016 10:46am
Maybe the smart ones, I imagine most of the CXR crowd have had it with growth-by-acquisition though. My guess is people who got out at $3.00 are thinking this is cheap again.  The insider buying is also a heartening sign, but I'm very confused why the stock is staying at this level with so much volume. Weak hands all over?
Comment by thedave2006 on Sep 23, 2016 5:36pm
mmm back on radar
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities